Diary - News
All news Aguettant signed an agreement with Baxter
Baxter International Inc. (NYSE:BAX) and Laboratoire Aguettant SAS, Lyon, France, today announced they have signed an exclusive global licensing and distribution agreement for trace elements, which are essential micronutrients used in parenteral nutrition (PN) therapy. The collaboration allows Baxter to augment its leading PN portfolio, currently available in more than 90 countries, with essential trace elements.
